Profile data is unavailable for this security.
About the company
Ortivus AB is a Sweden-based provider of mobile solutions for modern emergency medical services. The Company is engaged in the development of mobile surveillance and communication solutions, forming a decision support system. Its offering comprises: MobiMed Smart, a decision support system, which allows ambulance personnel to handle documentation, monitoring and introduce a structured approach in prehospital care; CoroNet, a mobile surveillance solution which allows patients to move freely under supervision of medical staff and provides healthcare professionals with monitoring information. In addition, the Company provides a wide range of services, such as support, implementation, training and consulting, among others. The Company’s customer base includes mainly ambulance services and emergency departments.
- Revenue in SEK (TTM)78.15m
- Net income in SEK-20.63m
- Incorporated1985
- Employees42.00
- LocationOrtivus ABSvardvagen 19DANDERYD 182 33SwedenSWE
- Phone+46 84464500
- Fax+46 84464519
- Websitehttps://www.ortivus.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kontigo Care AB | 29.47m | 775.00k | 67.30m | 10.00 | 64.00 | 1.88 | 14.81 | 2.28 | 0.0328 | 0.0328 | 1.17 | 1.12 | 0.6807 | -- | 7.69 | -- | 1.79 | -0.4214 | 2.55 | -0.6195 | 68.84 | 66.31 | 2.63 | -0.5205 | -- | 4.00 | 0.093 | -- | 1.80 | 16.95 | -92.68 | -- | 44.94 | -- |
| Glycorex Transplantation AB (publ) | 31.00m | -29.54m | 70.44m | 15.00 | -- | 1.82 | -- | 2.27 | -0.40 | -0.40 | 0.4197 | 0.5485 | 0.3978 | 0.7283 | 4.60 | 1,347,652.00 | -37.91 | -11.30 | -47.48 | -13.17 | 84.79 | 91.60 | -95.30 | -33.24 | 1.20 | -118.90 | 0.2046 | -- | -17.04 | -2.15 | -254.06 | -- | -0.5593 | -- |
| BBS-Bioactive Bone Substitutes Oyj | 0.00 | -39.77m | 83.87m | -- | -- | 1.37 | -- | -- | -0.2926 | -0.2926 | 0.00 | 0.2647 | 0.00 | -- | -- | -- | -32.71 | -25.12 | -38.23 | -28.54 | -- | -- | -- | -- | -- | -28.79 | 0.482 | -- | -- | -- | -12.64 | -- | -- | -- |
| Redsense Medical AB (publ) | 19.85m | -7.57m | 94.64m | 5.00 | -- | 4.76 | -- | 4.77 | -0.5389 | -0.5389 | 1.41 | 1.42 | 0.7261 | 4.51 | 5.02 | 3,970,800.00 | -27.67 | -18.66 | -31.75 | -20.99 | 50.11 | 69.02 | -38.11 | -46.28 | 2.21 | -- | 0.00 | -- | 74.11 | 28.94 | 48.47 | -- | -23.62 | -- |
| Luxbright AB | 952.90k | -25.38m | 95.44m | 10.00 | -- | 2.83 | -- | 100.16 | -0.2752 | -0.2752 | 0.0103 | 0.3653 | 0.0265 | -- | 1.99 | 95,290.00 | -70.61 | -61.39 | -81.90 | -70.36 | -947.28 | -559.15 | -2,662.94 | -2,459.34 | -- | -1,722.29 | 0.0061 | -- | 73.46 | -- | -20.07 | -- | -- | -- |
| Observe Medical ASA | 28.03m | -60.55m | 95.63m | 12.00 | -- | 0.8247 | -- | 3.41 | -1.05 | -1.05 | 0.4849 | 0.6063 | 0.1191 | 2.49 | 7.12 | 2,328,500.00 | -25.72 | -32.60 | -35.90 | -49.80 | 33.24 | 32.83 | -216.03 | -256.25 | 0.334 | -6.01 | 0.3204 | -- | 43.14 | 204.81 | -18.82 | -- | 32.69 | -- |
| ScandiDos AB | 65.08m | -4.85m | 102.62m | 34.00 | -- | 2.37 | -- | 1.58 | -0.1063 | -0.1063 | 1.43 | 0.7588 | 0.9573 | 0.4787 | 7.39 | -- | -7.14 | -13.82 | -13.39 | -23.95 | 82.54 | 82.49 | -7.45 | -17.09 | 0.4511 | -2.63 | 0.00 | -- | 6.70 | 4.01 | -24.27 | -- | 4.18 | -- |
| Nanexa AB | 28.91m | -70.62m | 127.83m | 19.00 | -- | 1.37 | -- | 4.42 | -0.8143 | -0.8143 | 0.3252 | 0.6854 | 0.2069 | -33.45 | 2.26 | 1,521,474.00 | -50.54 | -40.77 | -66.82 | -48.77 | 124.70 | 77.27 | -244.28 | -532.26 | 2.14 | -- | 0.0193 | -- | 925.42 | 147.00 | -30.44 | -- | 39.10 | -- |
| Ortivus AB | 78.15m | -20.63m | 128.62m | 42.00 | -- | 8.08 | -- | 1.65 | -0.4655 | -0.4655 | 1.76 | 0.3529 | 1.00 | 3.36 | 4.76 | 1,953,650.00 | -26.44 | -2.41 | -51.70 | -4.63 | 33.88 | 42.46 | -26.39 | -1.77 | 0.5256 | -- | 0.4544 | -- | -19.55 | 10.00 | -409.66 | -- | 67.43 | -- |
| Neola Medical AB | 0.00 | -9.04m | 139.60m | 7.00 | -- | 1.82 | -- | -- | -0.1536 | -0.1536 | 0.00 | 1.09 | 0.00 | -- | -- | 0.00 | -11.63 | -17.04 | -12.52 | -18.46 | -- | 4,237.20 | -- | -5,258.78 | -- | -- | 0.00 | -- | -- | -- | 12.97 | -- | 55.46 | -- |
| Dignitana AB | 85.74m | -18.48m | 144.57m | 28.00 | -- | 46.71 | -- | 1.69 | -0.2487 | -0.2487 | 1.15 | 0.0384 | 1.66 | 3.35 | 14.61 | 3,175,519.00 | -35.81 | -42.21 | -97.80 | -68.91 | 69.11 | 66.09 | -21.55 | -57.29 | 0.3234 | -8.84 | 0.8571 | -- | 17.90 | 20.59 | 22.52 | -- | -15.31 | -- |
| BibbInstruments AB | 0.00 | -10.97m | 153.87m | -- | -- | 4.93 | -- | -- | -0.4379 | -0.4379 | 0.00 | 1.18 | 0.00 | -- | -- | -- | -32.19 | -39.57 | -34.83 | -42.71 | -- | 59.36 | -- | -8,032.40 | -- | -- | 0.00 | -- | -- | -- | 2.72 | -- | -1.94 | -- |
| Iconovo AB | 8.47m | -42.40m | 191.82m | 29.00 | -- | 1.43 | -- | 22.65 | -3.68 | -3.68 | 0.703 | 8.45 | 0.0554 | -- | 1.24 | 292,079.00 | -27.74 | -25.43 | -30.85 | -28.24 | 234.21 | 134.57 | -500.63 | -215.16 | -- | -- | 0.0666 | -- | -58.65 | -9.88 | 4.71 | -- | 34.70 | -- |
Data as of Jun 03 2024. Currency figures normalised to Ortivus AB's reporting currency: Swedish Krona SEK
5.09%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Seligson & Co. Rahastoyhti� Oyjas of 30 Apr 2024 | 1.60m | 3.74% |
| Handelsbanken Fonder ABas of 30 Apr 2024 | 251.00k | 0.59% |
| SEB Investment Management ABas of 30 Apr 2024 | 112.36k | 0.26% |
| FCG Fonder ABas of 31 Dec 2023 | 107.81k | 0.25% |
| Skandia Investment Management ABas of 28 Mar 2024 | 67.45k | 0.16% |
| Evli Fund Management Co. Ltd.as of 30 Apr 2024 | 34.32k | 0.08% |
More ▼
Data from 31 Dec 2023 - 30 Apr 2024Source: FactSet Research Systems Inc.
